It creates multi-layered, localized, directional, and programmable transdermal penetration, enabling controlled drug absorption through the skin, tissue membranes, and cell membranes.

This mechanism helps bypass the first-pass hepatic metabolism, rapidly increases local drug concentration, prolongs drug efficacy, and enhances overall therapeutic outcomes.

The device has been registered with the Department of Health and is classified as a Class B medical device.

In addition, it is certified under international standards, including ISO 13485:2016.

The Electro-Phonophoresis (EP) Couplant Patch is a single-use consumable specifically designed for drug delivery therapy via ultrasound, utilizing patented proprietary technology. It simultaneously serves multiple functions, including electrical conduction protection, ultrasound penetration, drug transport, and isolation/fixation.